Global Antisense Oligonucleotide Drugs(ASO Drugs) Production, Demand and Key Producers, 2022-2028
A class of molecular drugs that inhibit gene expression and regulate at the gene level through sequence specific binding with target gene DNA or mRNA
This report studies the global Antisense Oligonucleotide Drugs(ASO Drugs) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antisense Oligonucleotide Drugs(ASO Drugs), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antisense Oligonucleotide Drugs(ASO Drugs) that contribute to its increasing demand across many markets.
The global Antisense Oligonucleotide Drugs(ASO Drugs) market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Antisense Oligonucleotide Drugs(ASO Drugs) total production and demand, 2017-2028, (K Units)
Global Antisense Oligonucleotide Drugs(ASO Drugs) total production value, 2017-2028, (USD Million)
Global Antisense Oligonucleotide Drugs(ASO Drugs) production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Antisense Oligonucleotide Drugs(ASO Drugs) consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Antisense Oligonucleotide Drugs(ASO Drugs) domestic production, consumption, key domestic manufacturers and share
Global Antisense Oligonucleotide Drugs(ASO Drugs) production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Antisense Oligonucleotide Drugs(ASO Drugs) production by Indication, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Antisense Oligonucleotide Drugs(ASO Drugs) production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Antisense Oligonucleotide Drugs(ASO Drugs) market based on the following parameters – headquarters, production locations, products portfolio, Antisense Oligonucleotide Drugs(ASO Drugs) revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antisense Oligonucleotide Drugs(ASO Drugs) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Indication, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Antisense Oligonucleotide Drugs(ASO Drugs) Market, By Region:
1. How big is the global Antisense Oligonucleotide Drugs(ASO Drugs) market?
2. What is the demand of the global Antisense Oligonucleotide Drugs(ASO Drugs) market?
3. What is the year over year growth of the global Antisense Oligonucleotide Drugs(ASO Drugs) market?
4. What is the production and production value of the global Antisense Oligonucleotide Drugs(ASO Drugs) market?
5. Who are the key producers in the global Antisense Oligonucleotide Drugs(ASO Drugs) market?
6. What are the growth factors driving the market demand?
This report studies the global Antisense Oligonucleotide Drugs(ASO Drugs) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Antisense Oligonucleotide Drugs(ASO Drugs), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antisense Oligonucleotide Drugs(ASO Drugs) that contribute to its increasing demand across many markets.
The global Antisense Oligonucleotide Drugs(ASO Drugs) market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Antisense Oligonucleotide Drugs(ASO Drugs) total production and demand, 2017-2028, (K Units)
Global Antisense Oligonucleotide Drugs(ASO Drugs) total production value, 2017-2028, (USD Million)
Global Antisense Oligonucleotide Drugs(ASO Drugs) production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Antisense Oligonucleotide Drugs(ASO Drugs) consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Antisense Oligonucleotide Drugs(ASO Drugs) domestic production, consumption, key domestic manufacturers and share
Global Antisense Oligonucleotide Drugs(ASO Drugs) production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Antisense Oligonucleotide Drugs(ASO Drugs) production by Indication, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Antisense Oligonucleotide Drugs(ASO Drugs) production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Antisense Oligonucleotide Drugs(ASO Drugs) market based on the following parameters – headquarters, production locations, products portfolio, Antisense Oligonucleotide Drugs(ASO Drugs) revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antisense Oligonucleotide Drugs(ASO Drugs) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Indication, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Antisense Oligonucleotide Drugs(ASO Drugs) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Hepatitis B
- Prostatitis
- Other
- Hospital
- Clinic
- Other
- Lonis
- Biogen
- Sarepta
- Novartis
- Antisense Therapeutics
- Akcea
- WAVE
1. How big is the global Antisense Oligonucleotide Drugs(ASO Drugs) market?
2. What is the demand of the global Antisense Oligonucleotide Drugs(ASO Drugs) market?
3. What is the year over year growth of the global Antisense Oligonucleotide Drugs(ASO Drugs) market?
4. What is the production and production value of the global Antisense Oligonucleotide Drugs(ASO Drugs) market?
5. Who are the key producers in the global Antisense Oligonucleotide Drugs(ASO Drugs) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Antisense Oligonucleotide Drugs(ASO Drugs) Introduction
1.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Supply & Forecast
1.2.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value (2017 & 2021 & 2028)
1.2.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028)
1.2.3 World Antisense Oligonucleotide Drugs(ASO Drugs) Pricing Trends (2017-2028)
1.3 World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Region
1.3.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Region (2017-2028)
1.3.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Region (2017-2028)
1.3.3 World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Region (2017-2028)
1.3.4 North America Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028)
1.3.5 Europe Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028)
1.3.6 China Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028)
1.3.7 Japan Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antisense Oligonucleotide Drugs(ASO Drugs) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Antisense Oligonucleotide Drugs(ASO Drugs) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Demand (2017-2028)
2.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption by Region
2.2.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption by Region (2017-2022)
2.2.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Forecast by Region (2023-2028)
2.3 United States Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
2.4 China Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
2.5 Europe Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
2.6 Japan Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
2.7 South Korea Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
2.8 ASEAN Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
2.9 India Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
3 WORLD ANTISENSE OLIGONUCLEOTIDE DRUGS(ASO DRUGS) MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Manufacturer (2017-2022)
3.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Manufacturer (2017-2022)
3.3 World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Manufacturer (2017-2022)
3.4 Antisense Oligonucleotide Drugs(ASO Drugs) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Antisense Oligonucleotide Drugs(ASO Drugs) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Antisense Oligonucleotide Drugs(ASO Drugs) in 2021
3.5.3 Global Concentration Ratios (CR8) for Antisense Oligonucleotide Drugs(ASO Drugs) in 2021
3.6 Antisense Oligonucleotide Drugs(ASO Drugs) Market: Overall Company Footprint Analysis
3.6.1 Antisense Oligonucleotide Drugs(ASO Drugs) Market: Region Footprint
3.6.2 Antisense Oligonucleotide Drugs(ASO Drugs) Market: Company Product Type Footprint
3.6.3 Antisense Oligonucleotide Drugs(ASO Drugs) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Comparison
4.1.1 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Comparison
4.2.1 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Comparison
4.3.1 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Antisense Oligonucleotide Drugs(ASO Drugs) Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Antisense Oligonucleotide Drugs(ASO Drugs) in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Antisense Oligonucleotide Drugs(ASO Drugs) Production by Domestic Manufacturer, (2017-2022)
4.5 China Antisense Oligonucleotide Drugs(ASO Drugs) Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Antisense Oligonucleotide Drugs(ASO Drugs) in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Antisense Oligonucleotide Drugs(ASO Drugs) Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Antisense Oligonucleotide Drugs(ASO Drugs) in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY INDICATION
5.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Market Size Overview by Indication: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Indication
5.2.1 Hepatitis B
5.2.2 Prostatitis
5.2.3 Other
5.3 Market Segment by Indication
5.3.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Indication (2017-2028)
5.3.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Indication (2017-2028)
5.3.3 World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Indication (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Application (2017-2028)
6.3.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Application (2017-2028)
6.3.3 World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Lonis
7.1.1 Lonis Details
7.1.2 Lonis Major Business
7.1.3 Lonis Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.1.4 Lonis Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Lonis Recent Developments/Updates
7.1.6 Lonis Competitive Strengths & Weaknesses
7.2 Biogen
7.2.1 Biogen Details
7.2.2 Biogen Major Business
7.2.3 Biogen Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.2.4 Biogen Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Biogen Recent Developments/Updates
7.2.6 Biogen Competitive Strengths & Weaknesses
7.3 Sarepta
7.3.1 Sarepta Details
7.3.2 Sarepta Major Business
7.3.3 Sarepta Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.3.4 Sarepta Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Sarepta Recent Developments/Updates
7.3.6 Sarepta Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.4.4 Novartis Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Antisense Therapeutics
7.5.1 Antisense Therapeutics Details
7.5.2 Antisense Therapeutics Major Business
7.5.3 Antisense Therapeutics Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.5.4 Antisense Therapeutics Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Antisense Therapeutics Recent Developments/Updates
7.5.6 Antisense Therapeutics Competitive Strengths & Weaknesses
7.6 Akcea
7.6.1 Akcea Details
7.6.2 Akcea Major Business
7.6.3 Akcea Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.6.4 Akcea Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Akcea Recent Developments/Updates
7.6.6 Akcea Competitive Strengths & Weaknesses
7.7 WAVE
7.7.1 WAVE Details
7.7.2 WAVE Major Business
7.7.3 WAVE Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.7.4 WAVE Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 WAVE Recent Developments/Updates
7.7.6 WAVE Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Antisense Oligonucleotide Drugs(ASO Drugs) and Key Manufacturers
8.2 Antisense Oligonucleotide Drugs(ASO Drugs) Manufacturing Costs
8.3 Antisense Oligonucleotide Drugs(ASO Drugs) Production Process
8.4 Antisense Oligonucleotide Drugs(ASO Drugs) Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Antisense Oligonucleotide Drugs(ASO Drugs) Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Antisense Oligonucleotide Drugs(ASO Drugs) Typical Distributors
9.3 Antisense Oligonucleotide Drugs(ASO Drugs) Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Antisense Oligonucleotide Drugs(ASO Drugs) Introduction
1.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Supply & Forecast
1.2.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value (2017 & 2021 & 2028)
1.2.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028)
1.2.3 World Antisense Oligonucleotide Drugs(ASO Drugs) Pricing Trends (2017-2028)
1.3 World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Region
1.3.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Region (2017-2028)
1.3.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Region (2017-2028)
1.3.3 World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Region (2017-2028)
1.3.4 North America Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028)
1.3.5 Europe Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028)
1.3.6 China Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028)
1.3.7 Japan Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Antisense Oligonucleotide Drugs(ASO Drugs) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Antisense Oligonucleotide Drugs(ASO Drugs) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Demand (2017-2028)
2.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption by Region
2.2.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption by Region (2017-2022)
2.2.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Forecast by Region (2023-2028)
2.3 United States Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
2.4 China Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
2.5 Europe Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
2.6 Japan Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
2.7 South Korea Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
2.8 ASEAN Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
2.9 India Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028)
3 WORLD ANTISENSE OLIGONUCLEOTIDE DRUGS(ASO DRUGS) MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Manufacturer (2017-2022)
3.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Manufacturer (2017-2022)
3.3 World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Manufacturer (2017-2022)
3.4 Antisense Oligonucleotide Drugs(ASO Drugs) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Antisense Oligonucleotide Drugs(ASO Drugs) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Antisense Oligonucleotide Drugs(ASO Drugs) in 2021
3.5.3 Global Concentration Ratios (CR8) for Antisense Oligonucleotide Drugs(ASO Drugs) in 2021
3.6 Antisense Oligonucleotide Drugs(ASO Drugs) Market: Overall Company Footprint Analysis
3.6.1 Antisense Oligonucleotide Drugs(ASO Drugs) Market: Region Footprint
3.6.2 Antisense Oligonucleotide Drugs(ASO Drugs) Market: Company Product Type Footprint
3.6.3 Antisense Oligonucleotide Drugs(ASO Drugs) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Comparison
4.1.1 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Comparison
4.2.1 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Comparison
4.3.1 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Antisense Oligonucleotide Drugs(ASO Drugs) Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Antisense Oligonucleotide Drugs(ASO Drugs) in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Antisense Oligonucleotide Drugs(ASO Drugs) Production by Domestic Manufacturer, (2017-2022)
4.5 China Antisense Oligonucleotide Drugs(ASO Drugs) Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Antisense Oligonucleotide Drugs(ASO Drugs) in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Antisense Oligonucleotide Drugs(ASO Drugs) Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Antisense Oligonucleotide Drugs(ASO Drugs) in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY INDICATION
5.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Market Size Overview by Indication: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Indication
5.2.1 Hepatitis B
5.2.2 Prostatitis
5.2.3 Other
5.3 Market Segment by Indication
5.3.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Indication (2017-2028)
5.3.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Indication (2017-2028)
5.3.3 World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Indication (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Application (2017-2028)
6.3.2 World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Application (2017-2028)
6.3.3 World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Lonis
7.1.1 Lonis Details
7.1.2 Lonis Major Business
7.1.3 Lonis Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.1.4 Lonis Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Lonis Recent Developments/Updates
7.1.6 Lonis Competitive Strengths & Weaknesses
7.2 Biogen
7.2.1 Biogen Details
7.2.2 Biogen Major Business
7.2.3 Biogen Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.2.4 Biogen Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Biogen Recent Developments/Updates
7.2.6 Biogen Competitive Strengths & Weaknesses
7.3 Sarepta
7.3.1 Sarepta Details
7.3.2 Sarepta Major Business
7.3.3 Sarepta Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.3.4 Sarepta Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Sarepta Recent Developments/Updates
7.3.6 Sarepta Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.4.4 Novartis Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Antisense Therapeutics
7.5.1 Antisense Therapeutics Details
7.5.2 Antisense Therapeutics Major Business
7.5.3 Antisense Therapeutics Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.5.4 Antisense Therapeutics Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Antisense Therapeutics Recent Developments/Updates
7.5.6 Antisense Therapeutics Competitive Strengths & Weaknesses
7.6 Akcea
7.6.1 Akcea Details
7.6.2 Akcea Major Business
7.6.3 Akcea Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.6.4 Akcea Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Akcea Recent Developments/Updates
7.6.6 Akcea Competitive Strengths & Weaknesses
7.7 WAVE
7.7.1 WAVE Details
7.7.2 WAVE Major Business
7.7.3 WAVE Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
7.7.4 WAVE Antisense Oligonucleotide Drugs(ASO Drugs) Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 WAVE Recent Developments/Updates
7.7.6 WAVE Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Antisense Oligonucleotide Drugs(ASO Drugs) and Key Manufacturers
8.2 Antisense Oligonucleotide Drugs(ASO Drugs) Manufacturing Costs
8.3 Antisense Oligonucleotide Drugs(ASO Drugs) Production Process
8.4 Antisense Oligonucleotide Drugs(ASO Drugs) Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Antisense Oligonucleotide Drugs(ASO Drugs) Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Antisense Oligonucleotide Drugs(ASO Drugs) Typical Distributors
9.3 Antisense Oligonucleotide Drugs(ASO Drugs) Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Region (2017-2022) & (USD Million)
Table 3. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Region (2023-2028) & (USD Million)
Table 4. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Region (2017-2022)
Table 5. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Region (2023-2028)
Table 6. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Region (2017-2022) & (K Units)
Table 7. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Region (2023-2028) & (K Units)
Table 8. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Region (2017-2022)
Table 9. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Region (2023-2028)
Table 10. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Antisense Oligonucleotide Drugs(ASO Drugs) Major Market Trends
Table 13. World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption by Region (2017-2022) & (K Units)
Table 15. World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Antisense Oligonucleotide Drugs(ASO Drugs) Producers in 2021
Table 18. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Antisense Oligonucleotide Drugs(ASO Drugs) Producers in 2021
Table 20. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Antisense Oligonucleotide Drugs(ASO Drugs) Company Evaluation Quadrant
Table 22. World Antisense Oligonucleotide Drugs(ASO Drugs) Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Antisense Oligonucleotide Drugs(ASO Drugs) Production Site of Key Manufacturer
Table 24. Antisense Oligonucleotide Drugs(ASO Drugs) Market: Company Product Type Footprint
Table 25. Antisense Oligonucleotide Drugs(ASO Drugs) Market: Company Product Application Footprint
Table 26. Antisense Oligonucleotide Drugs(ASO Drugs) Competitive Factors
Table 27. Antisense Oligonucleotide Drugs(ASO Drugs) New Entrant and Capacity Expansion Plans
Table 28. Antisense Oligonucleotide Drugs(ASO Drugs) Mergers & Acquisitions Activity
Table 29. United States VS China Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Antisense Oligonucleotide Drugs(ASO Drugs) Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Antisense Oligonucleotide Drugs(ASO Drugs) in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Antisense Oligonucleotide Drugs(ASO Drugs) Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Antisense Oligonucleotide Drugs(ASO Drugs) in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Antisense Oligonucleotide Drugs(ASO Drugs) Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Antisense Oligonucleotide Drugs(ASO Drugs) in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Indication, (USD Million), 2017 & 2021 & 2028
Table 48. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Indication (2017-2022) & (K Units)
Table 49. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Indication (2023-2028) & (K Units)
Table 50. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Indication (2017-2022) & (USD Million)
Table 51. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Indication (2023-2028) & (USD Million)
Table 52. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Indication (2017-2022) & (US$/Unit)
Table 53. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Indication (2023-2028) & (US$/Unit)
Table 54. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Application (2017-2022) & (K Units)
Table 56. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Application (2023-2028) & (K Units)
Table 57. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Application (2017-2022) & (USD Million)
Table 58. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Application (2023-2028) & (USD Million)
Table 59. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Lonis Basic Information, Manufacturing Base and Competitors
Table 62. Lonis Major Business
Table 63. Lonis Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 64. Lonis Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Lonis Recent Developments/Updates
Table 66. Lonis Competitive Strengths & Weaknesses
Table 67. Biogen Basic Information, Manufacturing Base and Competitors
Table 68. Biogen Major Business
Table 69. Biogen Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 70. Biogen Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Biogen Recent Developments/Updates
Table 72. Biogen Competitive Strengths & Weaknesses
Table 73. Sarepta Basic Information, Manufacturing Base and Competitors
Table 74. Sarepta Major Business
Table 75. Sarepta Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 76. Sarepta Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Sarepta Recent Developments/Updates
Table 78. Sarepta Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 82. Novartis Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Antisense Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Antisense Therapeutics Major Business
Table 87. Antisense Therapeutics Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 88. Antisense Therapeutics Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Antisense Therapeutics Recent Developments/Updates
Table 90. Antisense Therapeutics Competitive Strengths & Weaknesses
Table 91. Akcea Basic Information, Manufacturing Base and Competitors
Table 92. Akcea Major Business
Table 93. Akcea Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 94. Akcea Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Akcea Recent Developments/Updates
Table 96. WAVE Basic Information, Manufacturing Base and Competitors
Table 97. WAVE Major Business
Table 98. WAVE Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 99. WAVE Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 100. Antisense Oligonucleotide Drugs(ASO Drugs) Raw Material
Table 101. Key Manufacturers of Antisense Oligonucleotide Drugs(ASO Drugs) Raw Materials
Table 102. Antisense Oligonucleotide Drugs(ASO Drugs) Typical Distributors
Table 103. Antisense Oligonucleotide Drugs(ASO Drugs) Typical Customers
Table 1. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Region (2017-2022) & (USD Million)
Table 3. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Region (2023-2028) & (USD Million)
Table 4. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Region (2017-2022)
Table 5. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Region (2023-2028)
Table 6. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Region (2017-2022) & (K Units)
Table 7. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Region (2023-2028) & (K Units)
Table 8. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Region (2017-2022)
Table 9. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Region (2023-2028)
Table 10. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Antisense Oligonucleotide Drugs(ASO Drugs) Major Market Trends
Table 13. World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption by Region (2017-2022) & (K Units)
Table 15. World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Antisense Oligonucleotide Drugs(ASO Drugs) Producers in 2021
Table 18. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Antisense Oligonucleotide Drugs(ASO Drugs) Producers in 2021
Table 20. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Antisense Oligonucleotide Drugs(ASO Drugs) Company Evaluation Quadrant
Table 22. World Antisense Oligonucleotide Drugs(ASO Drugs) Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Antisense Oligonucleotide Drugs(ASO Drugs) Production Site of Key Manufacturer
Table 24. Antisense Oligonucleotide Drugs(ASO Drugs) Market: Company Product Type Footprint
Table 25. Antisense Oligonucleotide Drugs(ASO Drugs) Market: Company Product Application Footprint
Table 26. Antisense Oligonucleotide Drugs(ASO Drugs) Competitive Factors
Table 27. Antisense Oligonucleotide Drugs(ASO Drugs) New Entrant and Capacity Expansion Plans
Table 28. Antisense Oligonucleotide Drugs(ASO Drugs) Mergers & Acquisitions Activity
Table 29. United States VS China Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Antisense Oligonucleotide Drugs(ASO Drugs) Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Antisense Oligonucleotide Drugs(ASO Drugs) in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Antisense Oligonucleotide Drugs(ASO Drugs) Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Antisense Oligonucleotide Drugs(ASO Drugs) in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Antisense Oligonucleotide Drugs(ASO Drugs) Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Antisense Oligonucleotide Drugs(ASO Drugs) in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Indication, (USD Million), 2017 & 2021 & 2028
Table 48. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Indication (2017-2022) & (K Units)
Table 49. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Indication (2023-2028) & (K Units)
Table 50. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Indication (2017-2022) & (USD Million)
Table 51. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Indication (2023-2028) & (USD Million)
Table 52. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Indication (2017-2022) & (US$/Unit)
Table 53. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Indication (2023-2028) & (US$/Unit)
Table 54. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Application (2017-2022) & (K Units)
Table 56. World Antisense Oligonucleotide Drugs(ASO Drugs) Production by Application (2023-2028) & (K Units)
Table 57. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Application (2017-2022) & (USD Million)
Table 58. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Application (2023-2028) & (USD Million)
Table 59. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Lonis Basic Information, Manufacturing Base and Competitors
Table 62. Lonis Major Business
Table 63. Lonis Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 64. Lonis Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Lonis Recent Developments/Updates
Table 66. Lonis Competitive Strengths & Weaknesses
Table 67. Biogen Basic Information, Manufacturing Base and Competitors
Table 68. Biogen Major Business
Table 69. Biogen Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 70. Biogen Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Biogen Recent Developments/Updates
Table 72. Biogen Competitive Strengths & Weaknesses
Table 73. Sarepta Basic Information, Manufacturing Base and Competitors
Table 74. Sarepta Major Business
Table 75. Sarepta Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 76. Sarepta Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Sarepta Recent Developments/Updates
Table 78. Sarepta Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 82. Novartis Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Antisense Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Antisense Therapeutics Major Business
Table 87. Antisense Therapeutics Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 88. Antisense Therapeutics Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Antisense Therapeutics Recent Developments/Updates
Table 90. Antisense Therapeutics Competitive Strengths & Weaknesses
Table 91. Akcea Basic Information, Manufacturing Base and Competitors
Table 92. Akcea Major Business
Table 93. Akcea Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 94. Akcea Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Akcea Recent Developments/Updates
Table 96. WAVE Basic Information, Manufacturing Base and Competitors
Table 97. WAVE Major Business
Table 98. WAVE Antisense Oligonucleotide Drugs(ASO Drugs) Product and Services
Table 99. WAVE Antisense Oligonucleotide Drugs(ASO Drugs) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 100. Antisense Oligonucleotide Drugs(ASO Drugs) Raw Material
Table 101. Key Manufacturers of Antisense Oligonucleotide Drugs(ASO Drugs) Raw Materials
Table 102. Antisense Oligonucleotide Drugs(ASO Drugs) Typical Distributors
Table 103. Antisense Oligonucleotide Drugs(ASO Drugs) Typical Customers
LIST OF FIGURES
Figure 1. Antisense Oligonucleotide Drugs(ASO Drugs) Picture
Figure 2. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028) & (K Units)
Figure 5. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price (2017-2028) & (US$/Unit)
Figure 6. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Region (2017-2028)
Figure 7. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Region (2017-2028)
Figure 8. North America Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028) & (K Units)
Figure 9. Europe Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028) & (K Units)
Figure 10. China Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028) & (K Units)
Figure 11. Japan Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028) & (K Units)
Figure 12. Antisense Oligonucleotide Drugs(ASO Drugs) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Antisense Oligonucleotide Drugs(ASO Drugs) Demand (2017-2028) & (K Units)
Figure 15. World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Market Share by Region (2017-2028)
Figure 16. United States Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 17. China Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 18. Europe Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 19. Japan Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 20. South Korea Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 22. India Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Antisense Oligonucleotide Drugs(ASO Drugs) by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Antisense Oligonucleotide Drugs(ASO Drugs) Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Antisense Oligonucleotide Drugs(ASO Drugs) Markets in 2021
Figure 26. United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Antisense Oligonucleotide Drugs(ASO Drugs) in United States
Figure 30. Key Producers and Market Share of Antisense Oligonucleotide Drugs(ASO Drugs) in China
Figure 31. Key Producers and Market Share of Antisense Oligonucleotide Drugs(ASO Drugs) in Rest of World
Figure 32. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Indication, (USD Million), 2017 & 2021 & 2028
Figure 33. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Indication in 2021
Figure 34. Hepatitis B
Figure 35. Prostatitis
Figure 36. Other
Figure 37. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Indication (2017-2028)
Figure 38. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Indication (2017-2028)
Figure 39. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Indication (2017-2028) & (US$/Unit)
Figure 40. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Application in 2021
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Application (2017-2028)
Figure 46. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Application (2017-2028)
Figure 47. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Antisense Oligonucleotide Drugs(ASO Drugs) in 2021
Figure 49. Manufacturing Process Analysis of Antisense Oligonucleotide Drugs(ASO Drugs)
Figure 50. Antisense Oligonucleotide Drugs(ASO Drugs) Industrial Chain
Figure 51. Distribution Channel Breakdown for Antisense Oligonucleotide Drugs(ASO Drugs) Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. Antisense Oligonucleotide Drugs(ASO Drugs) Picture
Figure 2. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028) & (K Units)
Figure 5. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price (2017-2028) & (US$/Unit)
Figure 6. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Region (2017-2028)
Figure 7. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Region (2017-2028)
Figure 8. North America Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028) & (K Units)
Figure 9. Europe Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028) & (K Units)
Figure 10. China Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028) & (K Units)
Figure 11. Japan Antisense Oligonucleotide Drugs(ASO Drugs) Production (2017-2028) & (K Units)
Figure 12. Antisense Oligonucleotide Drugs(ASO Drugs) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Antisense Oligonucleotide Drugs(ASO Drugs) Demand (2017-2028) & (K Units)
Figure 15. World Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Market Share by Region (2017-2028)
Figure 16. United States Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 17. China Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 18. Europe Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 19. Japan Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 20. South Korea Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 22. India Antisense Oligonucleotide Drugs(ASO Drugs) Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Antisense Oligonucleotide Drugs(ASO Drugs) by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Antisense Oligonucleotide Drugs(ASO Drugs) Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Antisense Oligonucleotide Drugs(ASO Drugs) Markets in 2021
Figure 26. United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Antisense Oligonucleotide Drugs(ASO Drugs) Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Antisense Oligonucleotide Drugs(ASO Drugs) in United States
Figure 30. Key Producers and Market Share of Antisense Oligonucleotide Drugs(ASO Drugs) in China
Figure 31. Key Producers and Market Share of Antisense Oligonucleotide Drugs(ASO Drugs) in Rest of World
Figure 32. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Indication, (USD Million), 2017 & 2021 & 2028
Figure 33. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Indication in 2021
Figure 34. Hepatitis B
Figure 35. Prostatitis
Figure 36. Other
Figure 37. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Indication (2017-2028)
Figure 38. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Indication (2017-2028)
Figure 39. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Indication (2017-2028) & (US$/Unit)
Figure 40. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Application in 2021
Figure 42. Hospital
Figure 43. Clinic
Figure 44. Other
Figure 45. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Market Share by Application (2017-2028)
Figure 46. World Antisense Oligonucleotide Drugs(ASO Drugs) Production Value Market Share by Application (2017-2028)
Figure 47. World Antisense Oligonucleotide Drugs(ASO Drugs) Average Price by Application (2017-2028) & (US$/Unit)
Figure 48. Manufacturing Cost Structure Analysis of Antisense Oligonucleotide Drugs(ASO Drugs) in 2021
Figure 49. Manufacturing Process Analysis of Antisense Oligonucleotide Drugs(ASO Drugs)
Figure 50. Antisense Oligonucleotide Drugs(ASO Drugs) Industrial Chain
Figure 51. Distribution Channel Breakdown for Antisense Oligonucleotide Drugs(ASO Drugs) Shipments (%): 2017-2028
Figure 52. Direct Channel Pros & Cons
Figure 53. Indirect Channel Pros & Cons
Figure 54. Methodology
Figure 55. Research Process and Data Source
